N-heptane sales will expand through 2035, with 99% purity n-heptane at 44.2% of purity demand and pharmaceuticals at 31.0% of application sales in 2025. The market was valued at USD 828.4 million in 2025, is projected to reach USD 1,428.5 million by 2035 and is forecast to record a 5.6% CAGR between 2025 and 2035.